Pharmacosmos, founded in 1965, is a pharmaceutical company specializing in the development of treatments for iron deficiency and iron deficiency anaemia. With a significant global presence, the company employs more than 600 people, based in Denmark and at its affiliates in the US, China, the UK, Ireland, Germany, Sweden, and Norway. Pharmacosmos' products are currently available in 40 countries, supported by its own affiliates and a network of dedicated partners worldwide.